JE, V., S, O., S, A., M, B., & AM, A. (2022). 5-Aminolevulinic Acid-A Biomarker for Worse Prognosis in IDH-Wildtype II Tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: A Case Report. Journal of neurological surgery reports, 83(3), e95. https://doi.org/10.1055/a-1858-7628
Chicago Style (17th ed.) CitationJE, Valerio, Ochoa S, Alvarez S, Borro M, and Alvarez-Pinzon AM. "5-Aminolevulinic Acid-A Biomarker for Worse Prognosis in IDH-Wildtype II Tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: A Case Report." Journal of Neurological Surgery Reports 83, no. 3 (2022): e95. https://doi.org/10.1055/a-1858-7628.
MLA (9th ed.) CitationJE, Valerio, et al. "5-Aminolevulinic Acid-A Biomarker for Worse Prognosis in IDH-Wildtype II Tumors? Evolution of a Fluorescence-Positive Diffuse Astrocytoma: A Case Report." Journal of Neurological Surgery Reports, vol. 83, no. 3, 2022, p. e95, https://doi.org/10.1055/a-1858-7628.